Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study.
Amyloid
; 26(2): 74-84, 2019 Jun.
Article
in En
| MEDLINE
| ID: mdl-31119947
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prealbumin
/
Amyloid Neuropathies, Familial
/
Protein Aggregation, Pathological
/
Proof of Concept Study
/
Tolcapone
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Amyloid
Journal subject:
BIOQUIMICA
Year:
2019
Document type:
Article
Affiliation country:
Spain
Country of publication:
United kingdom